A Phase 4 interventional study of SET-diet plus clomiphene and Clomiphene citrate in Polycystic Ovary Syndrome and Anovulation, sponsored by University Magna Graecia. Completed at 1 site in Italy. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2010-11-03.
Sponsored by University Magna Graecia · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Polycystic Ovary Syndrome by University Magna Graecia — none open to participants now, none under way, none of them phase 3. Polycystic Ovary Syndrome · University Magna Graecia.
Among the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia, this one is the 3rd largest by enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2008, is one of 14 in phase 4, and was the 11th registered.
959 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.
Browse Polycystic Ovary Syndrome studies →None of the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia is open now. The open studies under Polycystic Ovary Syndrome, anywhere →
Of the 120 Polycystic Ovary Syndrome studies recruiting now, 11 (9%) set no upper age limit and 106 (88%) stop at 75 or younger; 23 take children under 18; 41 take healthy volunteers.
This study: 18 Years to 35 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2008.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 96 is above the median of 70 across 700 interventional studies indexed under Polycystic Ovary Syndrome.
Median enrollment 50 across the 15 interventional studies, 720 across the 1 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Magna Graecia is the lead sponsor of 75 studies on the registry; 5 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Clomiphene citrate (CC) is the first-line therapy for infertile women with polycystic ovary syndrome (PCOS). Unfortunately, at least 20% of PCOS results are not responsive to CC. Structured exercise training (SET) and diet has been successfully employed to restore ovarian function and to improve reproductive outcomes in obese and overweight women with PCOS. The current study was aimed to test the hypothesis that a short-term SET program plus diet intervention can improve the ovarian response to CC in CC-resistant PCOS patients.
Ninety-six PCOS patients considered CC-resistant because not responsive to 150 mg daily of CC were randomized in three arms (group A, B, and C). Group A underwent SET program plus hypocaloric diet for two months, group B had one month of observation followed by one-cycle of CC therapy, and group C underwent SET program plus hypocaloric diet for two months and received one-cycle of CC for one cycle. CC was always given at the maximal dose previously used. Clinical, hormonal and metabolic data were assessed at baseline and after intervention. Ovulation was monitored by ultrasound and confirmed by plasma progesterone assay.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Structured exercise program plus hypocaloric diet for two months and received one-cycle of clomiphene citrate for one cycle
Other: SET-diet plus clomiphene
One month of observation followed by one-cycle of clomiphene citrate therapy
Drug: Clomiphene citrate
Lifestyle modifications for two months.
Behavioral: Structured exercise program plus hypocaloric diet
Two months of structured exercise program plus hypocaloric diet followed by 150 mg daily of clomiphene citrate
Also known as: Lifestyle modification, CC
Clomiphene citrate at 150 mg daily for one cycle
Also known as: CC
SET plus diet
Also known as: Lifestyle modifications
Ovulation rate
Time frame: three months
Clinical data
Time frame: three months
Metabolic data
Time frame: three months
The record gives a start of Feb 2008, a primary completion of Oct 2009 and a completion of Oct 2009. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Magna Graecia